SoftWave therapy is FDA(510k) cleared for various indications, including improved blood supply, activation of connective tissue, temporary pain relief, treatment of chronic diabetic foot ulcers, and treatment of acute second-degree burns.
Moreover, SoftWave is a patented and clinically proven treatment option with a success rate ranging from 60-91% for various musculoskeletal and general pain complaints. This therapy is trusted by renowned medical institutions such as Cleveland Clinic, Shepherd’s Center, and Memorial Sloan Kettering, as well as professional sports teams like the Chicago Cubs and Pittsburgh Steelers.